Frank Bröcker

Title: Frank Bröcker: Innovator in Pharmaceutical Dosage Forms

Introduction

Frank Bröcker is a notable inventor based in Gevelsberg, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative dosage forms. His work focuses on improving the efficacy and delivery of medications.

Latest Patents

Frank Bröcker holds a patent for a pharmaceutical dosage form that comprises nifedipine or nisoldipine combined with an angiotensin II antagonist and/or a diuretic. This invention is characterized by the controlled release of nifedipine or nisoldipine in the body, while the angiotensin II antagonist and/or diuretic is released rapidly. The patent outlines processes for the preparation of these dosage forms and their use as medicaments for the treatment and prevention of various disorders.

Career Highlights

Frank Bröcker is associated with Bayer Intellectual Property GmbH, where he has been instrumental in advancing pharmaceutical innovations. His expertise in drug formulation has contributed to the development of effective treatment options for patients.

Collaborations

Throughout his career, Frank has collaborated with esteemed colleagues, including Alexander Kuhl and Erich Brendel. These partnerships have fostered a collaborative environment that enhances the innovation process.

Conclusion

Frank Bröcker's contributions to pharmaceutical dosage forms exemplify the importance of innovation in medicine. His work continues to impact the field positively, providing new solutions for patient care.